1. Aellig, W.H.: Venoconstrictor effect of dihydroergotamine in superficial hand veins. Europ. J. clin. Pharmacol. 7, 137–139 (1974)
2. Aellig, W.H., Nüesch, E.: Comparative pharmacokinetic investigations with tritium labelled ergot alkaloids after oral and after intravenous administration in man. Int. J. clin. Pharmacol. 15, 106–112 (1977)
3. Aghajanian, G.K., Bing, O.H.L.: Persistence of lysergic acid diethylamide in the plasma of human subjects. Clin. Pharmacol. Ther. 5, 611–614 (1964)
4. Agurell, S.: Biosynthesis of ergot alkaloids in Claviceps paspali. Part II. Incorporation of labelled agroclavine, elymoclavine, lysergic acid and lysergic acid methylester. Acta pharm. Suec. 3, 23–32 (1966a)
5. Agurell, S.: Biosynthesis of ergot alkaloids in Claviceps paspali: Incorporation of 6-methyl-Δ 8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H. Acta pharm. Suec. 3, 65–70 (1966b)